Immune Responses to Gene-Modified T Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|7|5|361-368

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.7, Iss.5, 2007-10, pp. : 361-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Immunotherapy Using Gene-Modified Dendritic Cells

By  

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 57-78

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotrophin-3 Gene-Modified Schwann Cells Promote TrkC Gene-Modified Mesenchymal Stem Cells to Differentiate into Neuron-Like Cells in Poly(Lactic-Acid-Co-Glycolic Acid) Multiple-Channel Conduit

By  

Cells Tissues Organs, Vol. 195, Iss. 4, 2011-08 ,pp. : 313-322

Karger

Access to resources Recommend Favorite

Immune Responses to Gene Product of Inducible Promoters

By  

Current Gene Therapy, Vol. 7, Iss. 5, 2007-10 ,pp. : 334-346

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1107-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Role of Regulatory T Cells in Gene Transfer

By  

Current Gene Therapy, Vol. 7, Iss. 5, 2007-10 ,pp. : 381-390

Bentham Science Publishers

Access to resources Recommend Favorite